IMR Press / RCM / Special Issues / cardiomyopathies_precision_medicine

Advances in Precision Medicine for Cardiomyopathies: from Genotype to Phenotype

Submission deadline: 31 March 2024
Special Issue Editor
  • Farbod Sedaghat-Hamedani, MD
    Institute for Cardiomyopathies Heidelberg (ICH), University of Heidelberg, Heidelberg, Germany
    Interests: cardiomyopathies; heart failure; precision medicine; interventional cardiology (PFO, ASD, LAAO)
Special Issue Information

Dear Colleagues,

We are delighted to introduce the special issue, "Advances in Precision Medicine for Cardiomyopathies: from Genotype to Phenotype." In this transformative era of biomedical research, precision medicine has emerged as a powerful approach that aims to tailor medical treatment to the individual characteristics of each patient. By understanding the genetic makeup that contributes to disease susceptibility and response to treatment, we aim to facilitate personalized care that aligns with an individual's unique genetic blueprint.

This special issue will illuminate the multifaceted realm of cardiomyopathies, a diverse range of diseases with primary cardiac muscle involvement. Conventionally, these conditions have been managed through a standardized therapeutic approach. However, with the advent of innovative genomics and genetic research, we have witnessed a paradigm shift in our understanding and treatment of cardiomyopathies. We now see the exciting prospect of precision medicine, personalized to cater to the genetic profiles of patients.

Our aim is to bridge the gap between the understanding of genetic variants and their clinical phenotypes, uncovering the potential of precision medicine in the management of cardiomyopathies. We invite research that spans the whole spectrum from basic genetic research, genotype-phenotype correlations, new diagnostic strategies, and advances in personalized treatment, to the impacts on patient outcomes and the broader healthcare system.

By fully exploring the potential of genomics and precision medicine, we can enhance our comprehension of the complex field of cardiomyopathies and facilitate the development of more targeted, efficacious treatments. We look forward to a rich assortment of contributions that will not only expand our current knowledge but also stimulate innovative investigations in this crucial domain.

Dr. Farbod Sedaghat-Hamedani
Guest Editor

Keywords
cardiomyopathies
precision medicine
genotype-phenotype correlation
genetic variations
personalized treatment
genetic pathogenesis
diagnostic strategies
genomic medicine
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Back to top